Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease
dc.contributor.author | Katsiki, N. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.date.accessioned | 2015-11-24T19:03:15Z | |
dc.date.available | 2015-11-24T19:03:15Z | |
dc.identifier.issn | 1473-4877 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19882 | |
dc.rights | Default Licence | - |
dc.subject | Cholesterol, LDL/*blood | en |
dc.subject | Female | en |
dc.subject | Glomerular Filtration Rate/*drug effects | en |
dc.subject | Heptanoic Acids/*administration & dosage | en |
dc.subject | Humans | en |
dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage | en |
dc.subject | Kidney/*physiopathology | en |
dc.subject | Male | en |
dc.subject | *Metabolic Syndrome X | en |
dc.subject | Pyrroles/*administration & dosage | en |
dc.subject | Uric Acid/*blood | en |
dc.title | Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1185/03007995.2011.596410 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21718096 | - |
heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.1185/03007995.2011.596410 | - |
heal.journalName | Current Medical Research and Opinion | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2011 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: